Interestingly, Mfn2 was shown to play a protective role in liver disease, as decreased levels of Mfn2 were shown in liver biopsies from patients with non-alcoholic steatohepatitis (NASH) and in mouse models of the condition. The gene discussed is MFN2; the disease is metabolic dysfunction-associated steatohepatitis.